BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruck JM, Segev DL. Expanding deceased donor kidney transplantation: medical risk, infectious risk, hepatitis C virus, and HIV. Curr Opin Nephrol Hypertens 2018;27:445-53. [PMID: 30169460 DOI: 10.1097/MNH.0000000000000456] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Piccoli GB, Cabiddu G, Breuer C, Jadeau C, Testa A, Brunori G. Dialysis Reimbursement: What Impact Do Different Models Have on Clinical Choices? J Clin Med 2019;8:E276. [PMID: 30823518 DOI: 10.3390/jcm8020276] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
2 Choudhury RA, Prins K, Dor Y, Moore HB, Yaffe H, Nydam TL. Uncontrolled donation after circulatory death improves access to kidney transplantation: A decision analysis. Clin Transplant 2020;34:e13868. [PMID: 32259310 DOI: 10.1111/ctr.13868] [Reference Citation Analysis]
3 Cuvelier S, Van Caeseele P, Kadatz M, Peterson K, Sun S, Dodd N, Werestiuk K, Koulack J, Nickerson P, Ho J. Expanding the Deceased Donor Pool in Manitoba Using Hepatitis C-Viremic Donors: Program Report. Can J Kidney Health Dis 2021;8:20543581211033496. [PMID: 34367648 DOI: 10.1177/20543581211033496] [Reference Citation Analysis]
4 Dent M, Hamorsky K, Vausselin T, Dubuisson J, Miyata Y, Morikawa Y, Matoba N. Safety and Efficacy of Avaren-Fc Lectibody Targeting HCV High-Mannose Glycans in a Human Liver Chimeric Mouse Model. Cell Mol Gastroenterol Hepatol 2021;11:185-98. [PMID: 32861832 DOI: 10.1016/j.jcmgh.2020.08.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]